![Tiina Seppä](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tiina Seppä
Consigliere Generale presso CERENO SCIENTIFIC AB
Provenienza dei contatti di primo grado di Tiina Seppä
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 12 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Tiina Seppä tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of Gothenburg | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
University of Lund | College/University | Director/Board Member Undergraduate Degree | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Sales & Marketing | |
Vicore Pharma AB
![]() Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
ACUCORT AB | Pharmaceuticals: Major | Chairman | |
STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Chairman | |
Monsanto Crop Sciences Sweden AB | Sales & Marketing | ||
SYNACT PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Synergon AB
![]() Synergon AB Miscellaneous Commercial ServicesCommercial Services Synergon AB offers strategic advice services to management of patent and trade mark portfolios. The private company is based in Lerum, Sweden. The CEO of the Swedish company is Jonas Per Åke Faijerson Säljö. | Miscellaneous Commercial Services | Chief Executive Officer | |
TikoMed AB
![]() TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
RLS GLOBAL AB (PUBL) | Biotechnology | Director of Finance/CFO | |
Crispin Porter Bogusky
![]() Crispin Porter Bogusky Advertising/Marketing ServicesCommercial Services Crispin Porter Bogusky is a creative agency that specializes in new media and caters to new types of audiences. The American company has offices in different parts of the world, including the US, Europe, and South America. The private company has helped businesses achieve success, even those that were once near bankruptcy. The company has also made the re-release of an iconic 20-year-old game more successful than ever before. The CEO of the company is Brad Simms. | Advertising/Marketing Services | Director of Finance/CFO | |
ADDNODE GROUP AB | Information Technology Services | Comptroller/Controller/Auditor | |
Softhouse Consulting Sydost AB | Director of Finance/CFO | ||
Växjö University of | College/University | Graduate Degree | |
Handelshögskolan i Göteborg | College/University | Masters Business Admin | |
University of Illinois | College/University | Doctorate Degree | |
University of Michigan | College/University | Corporate Officer/Principal | |
University of Michigan Medical School | College/University | Corporate Officer/Principal | |
IDOGEN AB (PUBL) | Biotechnology | Chairman | |
Säkerhetsbranschen AB | Chief Executive Officer | ||
Euralarm
![]() Euralarm Miscellaneous Commercial ServicesCommercial Services Euralarm is a trade association and industrial business that represents the fire safety and security industry. The private company is based in Zug, Switzerland. The Swiss company provides leadership and expertise for industry, market, policy makers, and standards bodies. The Security Section represents the intrusion, access, and video sector and is involved in standardization groups. Euralarm is at the forefront of the development of standards for services. The company circulates up-to-date market developments to keep informed of new innovations. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SARomics Biostructures AB
![]() SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | Biotechnology | Chairman | |
Amplifier TX AB
![]() Amplifier TX AB BiotechnologyHealth Technology Part of Cambrian BioPharma, Inc., Amplifier TX AB is a Swedish biopharmaceutical company that develops clinical molecule AMPK activators. The private company is based in Umeå, Sweden. The company was founded in 2023 by Thomas Edlund, Helena Edlund. James Hall has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Sahlgrenska University | College/University | Corporate Officer/Principal | |
VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member | |
Ostra Sjukhuset | Corporate Officer/Principal | ||
A+ Science AB
![]() A+ Science AB Miscellaneous Commercial ServicesCommercial Services A+ Science AB plans and conducts clinical trials for pharmaceutical and medical device companies. It offers outsourced research services to pharmaceutical companies. The company was founded in 1997 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Brazilinvest AB | Director/Board Member | ||
Scandinavian Cri AB | Director/Board Member | ||
Scandinavian CRI Holding AB | Director/Board Member | ||
Tandaxessen i Sverige | Director/Board Member | ||
Goldwater Sweden AB | Director/Board Member | ||
BD Medical Consulting AB | Director/Board Member | ||
J N K Clothing Co. AB | Corporate Officer/Principal | ||
PEXA AB | Medical Specialties | Director/Board Member | |
A+ Science Holding AB
![]() A+ Science Holding AB MiscellaneousMiscellaneous A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden. | Miscellaneous | Director/Board Member | |
Athera Biotechnologies AB
![]() Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman | |
The European Society of Cardiology | Director/Board Member | ||
BioCrine AB | Director/Board Member | ||
IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chief Executive Officer | |
Gesynta Pharma AB
![]() Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Karolinska Institutet | College/University | Doctorate Degree | |
International Institute for Management Development | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Svezia | 38 |
Stati Uniti | 5 |
Svizzera | 3 |
Regno Unito | 2 |
Giappone | 2 |
Settori
Health Technology | 16 |
Consumer Services | 11 |
Commercial Services | 6 |
Technology Services | 2 |
Producer Manufacturing | 2 |
Posizioni
Director/Board Member | 29 |
Corporate Officer/Principal | 13 |
Chairman | 9 |
Chief Executive Officer | 6 |
Doctorate Degree | 5 |
Contatti più connessi
- Borsa valori
- Insiders
- Tiina Seppä
- Connessioni Società